Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 482981 - 483000 out of 483189 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L04AC13) ixekizumab (adm: P) | TALTZ 40MG/0.5ML INJ,SYR,0.5ML | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | EliLilly&Company |
| USA | (L04AC21) bimekizumab (adm: P) | BIMZELX 160MG/ML INJ,AUTOINJECTOR | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB,Inc. |
| USA | (L04AC21) bimekizumab (adm: P) | BIMZELX 160MG/ML INJ,AUTOINJECTOR,PKG,2 | 2 | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB,Inc. |
| USA | (L04AC21) bimekizumab (adm: P) | BIMZELX 160MG/ML INJ,AUTOINJECTOR,PKG,2 | 2 | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB,Inc. |
| USA | (L04AC21) bimekizumab (adm: P) | BIMZELX 160MG/ML INJ,SYRINGE | 1 | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB,Inc. |
| USA | (L04AC21) bimekizumab (adm: P) | BIMZELX 160MG/ML INJ,SYRINGE,PKG,2 | 2 | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB,Inc. |
| USA | (L04AC21) bimekizumab (adm: P) | BIMZELX 160MG/ML INJ,SYRINGE,PKG,2 | 2 | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB,Inc. |
| USA | (L04AC21) bimekizumab (adm: P) | BIMZELX 160MG/ML INJ,AUTOINJECTOR,2M | 2ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB,Inc. |
| USA | (L04AC21) bimekizumab (adm: P) | BIMZELX 160MG/ML INJ,SYRINGE,2ML | 2ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Psoriasis | UCB,Inc. |
| USA | (L04AG03) natalizumab (adm: P) | TYSABRI 20MG/ML INJ | 15ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | BiogenU.S.Corporation |
| USA | (L04AG03) natalizumab (adm: P) | TYSABRI 20MG/ML INJ | 15ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | BiogenU.S.Corporation |
| USA | (L04AG08) ocrelizumab (adm: P) | OCREVUS ZUNOVO INJ,SOLN | 23ML | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | GenentechUSA,Inc. |
| USA | (L04AG16) rozanolixizumab | RYSTIGGO 140MG/ML INJ,VIL,2ML | 2ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Myasthenia Gravis | UCB,Inc. |
| USA | (L04AG16) rozanolixizumab | RYSTIGGO 140MG/ML INJ,VIL,2ML | 2ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Myasthenia Gravis | UCB,Inc. |
| USA | (L04AG16) rozanolixizumab | RYSTIGGO 420MG INJ | 3ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Myasthenia Gravis | UCB,Inc. |
| USA | (L04AG16) rozanolixizumab | RYSTIGGO 560MG INJ | 4ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Myasthenia Gravis | UCB,Inc. |
| USA | (L04AG16) rozanolixizumab | RYSTIGGO 840MG INJ | 6ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Myasthenia Gravis | UCB,Inc. |
| USA | (L04AJ06) zilucoplan | ZILBRYSQ 16.6MG/0.416ML INJ,SOLN SYRINGE | 28X0.416ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Myasthenia Gravis | UCB,Inc. |
| USA | (L04AJ06) zilucoplan | ZILBRYSQ 16.6MG/0.416ML INJ,SOLN SYRINGE | 28X0.416ML | Ex-factory price without vat |
$0-0 |
$0-0 |
Myasthenia Gravis | UCB,Inc. |
| USA | (L04AJ06) zilucoplan | ZILBRYSQ 23MG/0.574ML INJ,SOLN SYRINGE | 28 | Ex-factory price without vat |
$0-0 |
$0-0 |
Myasthenia Gravis | UCB,Inc. |
Pages
